| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5880318 | Cor et Vasa | 2014 | 5 Pages |
Abstract
In patients referred to the lipid clinic (typically because of side effects or failure to reach targets on other lipid-lowering therapy) treatment with ezetimibe significantly increased proportion of those achieving their target lipid levels. This was not accompanied by significant side effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michal Vrablik, Daniel Holmes, Barry Forer, Andrew Juren, Pawel Martinka, Jiri Frohlich,